Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Receptos, Auspex, Avelas, and More 01/10/14 San Diego
With New Funding, Avelas Moves Closer to Color-Coded Cancer Map 01/09/14 San Diego
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies 01/08/14 Seattle
Houston’s MD Anderson Partners With Pfizer on Cancer Immunotherapies 01/08/14 Texas
We Ask the Xconomists: Some Quick Predictions for the New Year 12/26/13 National
Texas Roundup: Apollo Endosurgery, Pros Holdings, START 12/20/13 Texas
San Diego Life Sciences Roundup: Rempex, Pfenex, Halozyme & More 12/19/13 San Diego
Exact Sciences, Once Near Death, Bounces Back With Colon Cancer Test 12/18/13 Wisconsin
For CytRx’s Insiders, What a Difference a Day Makes 12/17/13 National
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
A Revolution is Taking Place in the Treatment of Blood Cancers 12/16/13 National
San Diego Life Sciences Roundup: Orexigen, Accelrys, Otonomy, & More 12/13/13 San Diego
Novartis, Gilead, Genentech & More: An ASH 2013 Wrap-Up 12/10/13 National
Q&A: Behind Ignyta’s New Strategy on Cancer Drugs and Diagnostics 12/09/13 San Diego
Connect Honors Roth, Highlights Product Innovation in San Diego 12/06/13 San Diego
San Diego Life Sciences Roundup: Ignyta, Conatus, Liver Prize & More 12/06/13 San Diego
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
Blaze Bioscience Snags $9M More to Take “Tumor Paint” to the Clinic 12/03/13 Seattle
Modern Day Scrooges Are Ruining Our Health Care System 12/03/13 Seattle
3 Life Sciences Companies That Are Built to Last 12/02/13 National
San Diego Venture Group Picks Three Finalists for Annual PitchFest 11/26/13 San Diego
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
San Diego Life Sciences Roundup: IPOs, CareFusion, and More 11/22/13 San Diego
Big Pharma Quartet Puts $30M Behind Aileron’s P53 Peptide Drug 11/18/13 Boston
The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List 11/18/13 National
Pharmacyclics, J&J Win FDA Approval for Big Blood Cancer Drug 11/13/13 San Francisco
Dendreon Cuts 150 Jobs, As Prostate Cancer Drug Sales Decline 11/12/13 Seattle
San Diego Life Sciences Roundup: Santarus, Cytori, IPOs, and More 11/08/13 San Diego
Arno, With Potential Suitor in Opko, Goes After Endometrial Cancer 11/06/13 New York
Page 4 of 56 « previous page · next page »